Pharmaceuticals
Forest Labs to buy GI specialist Furiex in $1.46-bn deal
28 Apr 2014
Forest, which itself is in the process of being acquired by Actavis Plc for $25 billion, said that Actavis supported the deal
Greater investment needed to check malaria: WHO
25 Apr 2014
Britain’s Shire Plc recently rejected Allergan’s takeover approach: report
25 Apr 2014
Shire, the UK's third-biggest drug maker with a market cap of $33 billion, is itself an aggressive acquirer, having made 15 acquisitions since 2000
Valeant tables hostile $45.7 bn bid for Botox maker Allergan
23 Apr 2014
Valeant Pharmaceuticals International Inc, Canada's biggest drug maker and one of the most aggressive acquirers, yesterday tabled a hostile $45.7-billion cash and stock bid for Botox maker Allergan Inc
.webp)
.webp)
